AWARDDEFINITIVE CONTRACTSmall business
Definitive contract HHSN272201700079CAPHIOS CORP
Overview
Award facts
- Net obligations
- $299.59K
- $299,591of $299.59K potential value
- Period of performance
- Aug 1, 2018 to Jan 31, 2019
- Ended
- Modifications
- 1
- Latest action Jul 26, 2018
- Contract type
- Definitive contract
- PIID HHSN272201700079C
Description of requirement
IGF::OT::IGF CRITICAL FLUID NANOSOMES FOR EFFECTIVE TARGETED DELIVERY AND MANUFACTURE OF SIRNA-BASED THERAPEUTICS
Dates and value
- Award date
- Signed on Jul 27, 2017
- Potential end of performance
- Jan 30, 2019
- Current value
- $299,591Base and exercised options
- Potential value (if all options are exercised)
- $299,591
Obligations by fiscal year of action
- FY2017: $299,591
Total across 1 fiscal year: $299,591
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 26, 2018. View on USAspending · Recipient on SAM.gov
Recipient
NameAPHIOS CORP
LocationWOBURN, MA
UEIHDE2J1H521A7
CAGE code06PV8
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyAPHIOS CORP
Business types and certifications
Minority-ownedFor-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded from
- 075-0885Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Woburn, Middlesex County, Massachusetts 01801-1720
- Congressional district (place of performance)
- MA-05As reported at the time of the action
Classification and competition
Classification
Competition
- Extent competed
- Full and open competition after exclusion of sourcesD
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- Small business set aside - totalSBA
- Contract pricing
- Firm fixed priceJ
- Offers received
- 3
Solicitation and notices
- Solicitation ID
- PHS 20171(as reported)
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Critical fluid nanosomes for effective targeted delivery and manufacture of sirna-based therapeutics
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial item procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Jul 27, 2017Base obligation at award: $299,591
- Latest action
- Jul 26, 2018 — Other administrative actionModification 1; administrative: no change in scope or value
- Actions by type
- Base award1
- Other administrative action1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Research program (SBIR/STTR)
- Small business innovation research program phase i actionSR1
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 2
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930
- Treasury accounts
- 075-2017/2017-0885-000
- Object classes
- 25.5: Research and development contracts